Topics

Molecular diagnostics firm Atonarp secures £26.8m in Series C funding

11:36 EDT 26 Aug 2019 | Compelo Medical Devices

Molecular diagnostics company Atonarp has raised $33m (£26.8m) in the Series C funding round that saw the participation of five new investors. In an oversubscribed series C funding

The post Molecular diagnostics firm Atonarp secures £26.8m in Series C funding appeared first on NS Medical Devices.

Original Article: Molecular diagnostics firm Atonarp secures £26.8m in Series C funding

NEXT ARTICLE

More From BioPortfolio on "Molecular diagnostics firm Atonarp secures £26.8m in Series C funding"

Quick Search

Relevant Topic

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...